The Trump administration’s recent push for psychedelic drugs in mental healthcare may significantly shake up the industry.

Rep. Jack Bergman (R-Mich.) said on Tuesday that “the time is now” to push for breakthroughs in psychedelic treatments given ...

Adults with a history of childhood trauma who use psychedelics at raves or ceremonies may experience mental health ...

A recent study published in Translational Psychiatry provides evidence that individuals who experience persistent visual ...

Psychedelic drug experiences are among the most fascinating but mysterious journeys of the human mind. Long the domain of ...

SRx Health, which is merging with EMJ Crypto Technologies, said EMJ’s proprietary operating system used quantitative models and artificial intelligence to pick Optimi Health as an investment ...

Can a psychedelic drug with heavy side-effects and anecdotal evidence as a treatment for addiction become a wonder drug for ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

President Donald Trump aims to fast-track research into psychedelic therapy for conditions like post traumatic stress disorder and depression in a break from his first administration policy. Advocates ...

The FDA announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. It's a significant step toward supporting psychedelic-based medicines ...

Commenters on the US Food and Drug Administration’s (FDA) first guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug ...

Lawmakers are considering legislation that would fund research into the use of a psychedelic drug in addressing mental health ...